with a marginal significance (p ¼ 0.069). On multivariate analysis, PRS was an independent predictor for PFS (HR 0.33, p ¼ 0.002) along with distant metastasis (HR 1.84, p ¼ 0.032) and good Cx response (HR 0.44, p ¼ 0.002). PRS was also an independent predictor for OS (HR 0.21, p < 0.001). The 3Y PFS and OS rates for patients with and without PRS were 49% vs. 4% and 57% vs. 5%, respectively (both p < 0.001).
INTRODUCTION AND OBJECTIVES: Significant weight loss after surgery is reported to correlate with an increase in post-operative morbidity and mortality. However, there is limited evidence regarding the prevalence of weight loss in patients undergoing radical cystectomy (RC) for bladder cancer. We evaluated post-operative weight loss following RC and ileal neobladder construction, and examined possible association with overall survival outcomes.
METHODS: Single institution retrospective observational analysis was performed of patients who underwent RC for muscle invasive bladder cancer, in whom pre-and postoperative weights were documented at regular intervals. Preoperative weight and post-operative weight at 1 week, and 1 month were examined, as well as demographic clinical information. We evaluated weight loss at 1 month, post-operative complications, and relationship between weight loss and prognosis. Overall survival in patients with significant weight loss (¼<10% vs. >10%) was estimated using the Kaplan-Meier methods and compared with the log rank test. Risk factors for poor overall survival were determined by multivariate cox regression analysis.
RESULTS: Between March 1996 and Dec 2013, we performed RC in 348 patients and 204 received orthotopic ileal neobladder construction. Of those, a total of 192 patients met the search criteria Weight loss greater than 10% at 1 month was used as the threshold to distinguish patients who had significant weight loss. Patients with significant weight loss had more high-grade complications (¼ Clavien grade 3) within 1 month (16%% vs 2%, P¼0.014), and were significantly poor overall survival (P¼0.004). Multivariate analysis showed positive lymph node (HR: 3.2, P¼0.009) and postoperative weight loss greater than 10% at 1 month (HR: 3.9, P¼0.003) were selected as independent risk factor for overall survival.
CONCLUSIONS: Patients experience 5% of weight loss following RC. Patients who experienced > 10% weight loss from baseline at 1 month had increased high-grade complications and experienced poor prognosis. Although the limitations of this study design prevent further understanding of cause and effect, perioperative nutritional optimization may prevent significant weight loss and/or improve outcomes. METHODS: We identified 98 patients who had pathologically confirmed PCV on transurethral resection or RC and 1312 patients with pure UC and no variant history who underwent RC at our institution between January 1995 and December 2014. Univariable and multivariable Cox regression and Cox proportional hazards regression to determine if PCV histology was associated with overall survival (OS).
RESULTS: Patients with PCV were younger (p¼0.012), more likely to have advanced tumor stage (pT3/pT4, p¼0.002), positive lymph nodes (p¼0.038), and receive neoadjuvant chemotherapy than those with pure UC (45% versus 21%, p<0.0001). Rate of positive soft tissue surgical margins was over five times greater in the PCV group compared with the pure UC group (22% versus 4%, respectively, p<0.0001). Median OS for the pure UC group vs the PCV group were 8 and 3.8 years, respectively. On univariable analysis, PCV histology was associated with an increased risk of overall mortality (HR¼1.34; 95% CI 1.02e1.78; p¼0.039). However, on multivariable analysis adjusted for age, gender, neoadjuvant chemotherapy received, lymph node status, and pathologic stage, the association between PCV and OS was no longer significant (HR¼1.13; 95% CI 0.84e1.51; p¼0.4).
CONCLUSIONS: Patients with PCV features have higher disease burden at RC compared with those with pure UC. However, PCV was not an independent predictor of survival after RC on multivariable analysis, suggesting that PCV histology cannot be used as a prognostic factor.
